Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 4

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 9C
Chunk 4
---
Item 9C.     Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

None applicable.

71

PART III

We expect to file a definitive proxy statement relating to our 2025 Annual Meeting of Stockholders (the “2025 Proxy Statement”) with the United States Securities and Exchange Commission, pursuant to Regulation 14A, not later than 120 days after the end of our most recent fiscal year. Accordingly, certain information required by Part III has been omitted under General Instruction G(3) to Form 10-K. Only the information from the 2025 Proxy Statement that specifically addresses disclosure requirements of Items 10-14 below is incorporated by reference.